By Sabela Ojea
Shares of Talaris Therapeutics on Friday climbed 5.2% to $2.70 in after-hours trading after it declared a special dividend.
The biotechnology company said the special payout to shareholders, to be paid in cash, is expected to be $1.51 per share. It is conditional upon closing its merger deal with Tourmaline Bio.
Talaris Therapeutics signed a deal with the healthcare services company on June 22.
The board will vote in favor or against the merger on Oct. 17.
Write to Sabela Ojea at [email protected]; @sabelaojeaguix
Read the full article here